Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-CABG Study
NCT00000463Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Apr 1987
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of lovastatin, warfarin in transplant coronary artery disease (CAV), Graft occlusion, sponsored by National Heart, Lung, and Blood Institute. Started Apr 1987; status: completed.
02
Drugs
lovastatinwarfarin
03
Conditions
transplant coronary artery disease (CAV)Graft occlusion
Beyond the preview
Go deeper on NCT00000463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000463.